The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Late Spring 2021’s Awards, Appointments & Announcements in Rheumatology

Late Spring 2021’s Awards, Appointments & Announcements in Rheumatology

April 17, 2021 • By Gretchen Henkel

  • Tweet
  • Email
Print-Friendly Version / Save PDF

AMA Honors Mark Andrejeski with Lifetime Achievement Award

Mark AndrejeskiIn November 2020, the American Medical Association (AMA) presented Mark Andrejeski, the recently retired executive vice president of the ACR, with its Medical Executive Lifetime Achievement Award. The award honors a medical association executive who has contributed substantially to the goals and ideals of the medical profession.

You Might Also Like
  • Spring 2021’s Awards, Appointments & Announcements in Rheumatology
  • Spring 2020’s Awards, Appointments & Announcements in Rheumatology
  • Winter 2021’s Awards, Appointments & Announcements in Rheumatology
Explore This Issue
April 2021
Also By This Author
  • More Data for Treat to Target: Post-Hoc Analysis of Large RA Clinical Trials Supports Treat-to-Target Recommendations

“When Mark Andrejeski started at ACR, it was a fledgling society recently separated from the Arthritis Foundation. Under his tireless leadership, ACR membership has grown to more than 9,500 rheumatology professionals worldwide. Organized medicine depends on exceptional leaders like him to ensure our profession is represented at the state and federal levels. It is an honor to present him with this award for a lifetime of service,” said AMA Board Chair Russ Kridel, MD.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Mr. Andrejeski joined the ACR in 1987, when it was still known as the American Rheumatism Association and had only recently separated from the Arthritis Foundation. Just two years into his appointment, he guided the College through its renaming.

Into the 1990s, Mr. Andrejeski introduced advocacy efforts to ensure fair payer reimbursements for rheumatologists. “As we grew as an organization, our legislative and government affairs area grew too,” he notes. He also established a government affairs program that furnishes multiple resources to state societies and has taken rheumatologists’ advocacy with policymakers at both the state and federal levels to a higher and more sophisticated level.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Of the many initiatives Mr. Andrejeski guided while at the ACR, he is perhaps most proud of his role in establishing the Rheumatology Research Foundation Fellowship Program. “If you compare the number of fellows now in training programs to when we started, the number is double,” he says.

The initial focus of the Rheumatology Research Foundation was to encourage more physicians to specialize in rheumatology, he recalls. Coupled with the great science around biologics, the field became revitalized. “We actually gave training grants to institutions to encourage the establishment of additional positions for fellows for a two-year program.”

Guiding the growth of the Foundation was just one of many projects in his 32 years with the College.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Alexis Ogdie-Beatty Named Deputy Director of the Penn Center for Clinical Epidemiology & Biostatistics

Alexis R. Ogdie-Beatty, MD, MSCEAlexis R. Ogdie-Beatty, MD, MSCE, was appointed deputy director of the Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania (Penn), Philadelphia, in January. She is currently associate professor of medicine and epidemiology at the Hospital of the University of Pennsylvania, and now combines patient care, as director of the Penn Psoriatic Arthritis and Spondyloarthritis Program, with her ongoing research projects and oversight of investigations from the epidemiological perspective.

“What I love about my job,” she says, “is that I get to do problem-solving all the time. One day a week I am figuring out how to solve the problems of patients who are living with this very complex disease. Then, during the other parts of the week, I am dealing with problems from a larger epidemiological perspective to answer the questions about how patients respond to therapy, and how we measure disease.”

Dr. Ogdie-Beatty did her undergraduate work at the University of Minnesota and obtained her medical degree at Georgetown University School of Medicine, Washington, D.C., in 2006.

While a resident at Penn, she developed an early interest in inflammatory arthritis, intrigued by the hepatitis C patients who developed inflammatory arthritis and joint pain. Later, as a first-year fellow at Penn, she spent time in Joel Gelfand, MD’s dermatology clinic and realized that psoriasis patients were the perfect population in which to study why patients develop inflammatory arthritis and that the dermatology/rheumatology interface was where she wanted to focus her research.

Following her fellowship, she completed a Master of Science in Clinical Epidemiology in 2012, also at Penn, to integrate pharmacoepidemiology and observational methodology into studies of psoriatic arthritis.

She recently obtained a certificate in healthcare innovation to better understand development of interventions that can be deployed remotely to improve health outcomes. As the coronavirus pandemic evolves, Dr. Ogdie-Beatty reports that telemedicine has been an effective tool for patient care.

Dr. Ogdie-Beatty is currently leading studies investigating risk factors for psoriatic arthritis, its treatment and long-term outcomes, such as cardiovascular disease, seen in these patients. One current study, in collaboration with Dr. Gelfand and Rinad Beidas, PhD, a professor of medical ethics and health policy at Penn, draws from implementation science to inform design of a randomized trial of statin prescribing among patients with psoriatic disease.

Many of Dr. Ogdie-Beatty’s research studies have been conducted with colleagues who are also members of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). She co-chaired the GRAPPA-OMERACT Psoriatic Arthritis Working Group from 2014–18, working directly with patient research partners, and now sits on the organization’s steering committee.

Pages: 1 2 3 4 | Single Page

Filed Under: Awards, Profiles Tagged With: Dr. Alexis R. Ogdie-Beatty, Dr. Andrea Knight, Dr. Francesco Boin, Mark AndrejeskiIssue: April 2021

You Might Also Like:
  • Spring 2021’s Awards, Appointments & Announcements in Rheumatology
  • Spring 2020’s Awards, Appointments & Announcements in Rheumatology
  • Winter 2021’s Awards, Appointments & Announcements in Rheumatology
  • Awards, Appointments & Announcements in Rheumatology

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)